{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:06:03Z","timestamp":1782785163544,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.yebeh.2003.08.030","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T12:01:05Z","timestamp":1068897665000},"page":"788-792","source":"Crossref","is-referenced-by-count":24,"title":["Rasmussen\u2019s syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult"],"prefix":"10.1016","volume":"4","author":[{"given":"A.H.","family":"Lagrange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Blaivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gomez-Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Malow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2003.08.030_BIB1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00261-8","article-title":"Antibodies against GluR3 peptides are not specific for Rasmussen\u2019s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures","volume":"131","author":"Mantegazza","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.yebeh.2003.08.030_BIB2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0896-6273(00)00118-5","article-title":"Autoimmunity to munc-18 in Rasmussen\u2019s encephalitis","volume":"28","author":"Yang","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2003.08.030_BIB3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.8.6.435","article-title":"Focal seizures due to chronic localized encephalitis","volume":"8","author":"Rasmussen","year":"1958","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.yebeh.2003.08.030_BIB4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/brain\/awf176","article-title":"The natural history of Rasmussen\u2019s encephalitis","volume":"125","author":"Bien","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2003.08.030_BIB5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archneur.1993.00540030035011","article-title":"Rasmussen\u2019s chronic encephalitis in adults","volume":"50","author":"McLachlan","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.yebeh.2003.08.030_BIB6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/WNL.48.2.418","article-title":"Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen\u2019s syndrome","volume":"48","author":"Hart","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.08.030_BIB7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/smrv.1999.0069","article-title":"Narcolepsy: genetic predisposition and neuropharmacological mechanisms (Review article)","volume":"4","author":"Nishino","year":"2000","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.yebeh.2003.08.030_BIB8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/367781","article-title":"HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course","volume":"72","author":"Barcellos","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yebeh.2003.08.030_BIB9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.41.3.447","article-title":"Multiple sclerosis and narcolepsy: possible similar genetic susceptibility","volume":"41","author":"Younger","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.08.030_BIB10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ana.10444","article-title":"The neurobiology, diagnosis, and treatment of narcolepsy","volume":"53","author":"Scammell","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yebeh.2003.08.030_BIB11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.57.3.539","article-title":"Narcolepsy associated with other central nervous system disorders","volume":"57","author":"Malik","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.08.030_BIB12","first-page":"375","article-title":"Narcolepsy in systemic lupus erythematosus","volume":"20","author":"Pablos","year":"1993","journal-title":"J. Rheumatol."}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003002300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003002300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T02:51:33Z","timestamp":1550371893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505003002300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1525505003002300"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2003.08.030","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}